Dianthus therapeutics to participate in the jefferies global healthcare conference

New york and waltham, mass., may 30, 2024 (globe newswire) -- dianthus therapeutics, inc. (nasdaq: dnth), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced its participation in the jefferies global healthcare conference. marino garcia, chief executive officer, will present a corporate overview on thursday, june 6, 2024 at 1:30 p.m. et in new york.
DNTH Ratings Summary
DNTH Quant Ranking